Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. - Wikidata - awgldk - TriplyDB

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.

http://www.wikidata.org/entity/Q45223627

about

Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile A cluster of Candida krusei infections in a haematological unit.Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei.Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.Voriconazole in the management of nosocomial invasive fungal infections.Determination of antifungal susceptibility patterns among the clinical isolates of Candida species Antiproliferative effect and characterization of a novel antifungal peptide derived from human Chromogranin A.Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against Candida krusei Candida krusei: biotechnological potentials and concerns about its safety.The Candida pathogenic species complex.Risk factors for fluconazole-resistant candidemia.Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection.Strain typing and determination of population structure of Candida krusei by multilocus sequence typing.In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.Photodynamic inactivation of four Candida species induced by photogem(®).Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?Novel antifungal activity of purpurin against Candida species in vitro.Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei.ERG11 mutations and upregulation in clinical itraconazole-resistant isolates of Candida krusei.CGA-N12, a peptide derived from chromogranin A, promotes apoptosis of Candida tropicalis by attenuating mitochondrial functions.

P2860

Q28260910-49655B0D-11ED-43B7-8395-9D1C35C99F9E Q28489096-B5B53D90-CF0B-47B6-9B45-5FE9783D0091 Q33294780-3AF70147-68D5-422C-8C11-2CD7D5247BB1 Q33724155-DF427658-79DC-4F48-8170-E24E6DED3BB2 Q34856747-064C749B-5908-49F3-990D-BE761124A9C9 Q35166823-431CBE9E-D0AD-4A57-9DAB-F53489D2E5ED Q35646997-46871BD9-9087-4CF1-88A7-2335BD3B7505 Q36334389-75A3DD50-AFBB-4FF0-9D41-F7AD88EB5DAF Q36335705-158A8E01-3846-4415-892E-75FB53D9F19B Q38028552-87D774FC-C841-4FDB-8DD0-43972CE345AB Q38245727-A0A7090D-3245-4569-BC4A-E501186D83DE Q39934814-F7C7C693-AE4B-46DF-B8EE-258F24263515 Q40163927-2F94E463-CEAC-4322-A172-F9C3B9129B79 Q41819710-55AC257D-C359-4BE0-8923-31E7C188C35C Q42109755-C7D35C3C-0AC1-47F2-A747-472F6705393A Q42111638-BDEBE9EE-951C-4865-8F4F-1A86DFF55A55 Q42593820-9BB3D6CC-9604-41C8-83B0-F82290877512 Q43079484-426FC968-83C2-415A-9CB2-ABDC694C0BA5 Q43099651-A7F42573-B119-4CA6-8AC2-A550D4C7BA57 Q43737173-72C75CF5-14FF-4366-8ED8-C09B9089F0B5 Q50053143-260F68BE-E799-409C-BF67-5E3B683AC3D8 Q51512831-6649BF14-EFB8-480D-AA96-0DD6050DCD4D Q52646178-3B8725C7-F47F-4AD2-BC6A-891D2FD4283B

P2860

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.

http://www.wikidata.org/entity/Q45223627

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Candida krusei fungaemia: anti ...... in a single general hospital.

@en

Candida krusei fungaemia: anti ...... in a single general hospital.

@nl

type

label

Candida krusei fungaemia: anti ...... in a single general hospital.

@en

Candida krusei fungaemia: anti ...... in a single general hospital.

@nl

prefLabel

Candida krusei fungaemia: anti ...... in a single general hospital.

@en

Candida krusei fungaemia: anti ...... in a single general hospital.

@nl

P1433

Q45223627-547C72E5-BCF4-4452-9ADC-A7695D89CBEE

P1476

Q45223627-53EB114A-B4DC-4CA1-8EF7-D90E7B4B3170

P2093

Q45223627-115BE694-D7C8-4759-8FE6-631D4EEFAD15

Q45223627-9B77E4D0-B5A2-4B85-A358-3696FB8B4F3E

Q45223627-B23194C6-1D0E-4228-B589-5DF08859124F

Q45223627-F8448AF2-A6CD-4585-92D9-273F17478C54

Q45223627-FEB91F0E-E84B-4C7D-A0AF-EC1A09FC92E3

P2860

Q45223627-0CDEAA46-AE3E-4641-BB74-82639B2DD24A

Q45223627-2FB1086C-8B5E-4C2A-9559-B3586090E6EA

Q45223627-3F7426E5-88BC-4249-A181-31347013871C

Q45223627-403D64A9-50EA-4F18-A7CA-97AEB7BD264E

Q45223627-64A6F5E7-1CFA-4B6D-86C9-9B25EB788C03

Q45223627-6BD9B637-CE88-4C5C-B00E-8E093681F2CB

Q45223627-7287AD3E-E457-44F7-BA66-43F060A27837

Q45223627-757E34D8-B118-4999-B5D9-7BCE0906B967

Q45223627-791A5632-D994-42F2-9773-DD62AB3FAB4D

Q45223627-98459000-4296-47FC-85E4-BA3A562CBE30

P304

Q45223627-B33C14B0-6092-42AA-A5CC-3E6298E876FC

P31

Q45223627-E135B1B8-054E-4E95-A77E-022D3A0AF507

P356

Q45223627-6FBDD09A-6B53-476E-BAE5-39194D1BE080

P407

Q45223627-361260B3-E8C0-4BC5-A042-BF5CEB4E31BE

P433

Q45223627-2A1537A6-9F65-49B8-89B4-C992CB9A4117

P478

Q45223627-337EF8EE-6064-491B-8C82-5798B7DD8145

P50

Q45223627-7F54ACAE-F1A2-4A46-B5A9-691D91D22443

P577

Q45223627-CD322C6B-D50A-420E-9F48-7591B0F002C0

P5875

Q45223627-718C3321-D51F-4414-8690-D69EC68F5A6C

P698

Q45223627-3B743E26-987E-4631-AF7E-2A9F5B324878

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Candida krusei fungaemia: anti ...... in a single general hospital.

@en

P2093

Luis Alcalá

http://www.w3.org/2001/XMLSchema#string

Mar Sánchez-Somolinos

http://www.w3.org/2001/XMLSchema#string

Marta Rodríguez-Créixems

http://www.w3.org/2001/XMLSchema#string

Patricia Muñoz

http://www.w3.org/2001/XMLSchema#string

Teresa Peláez

http://www.w3.org/2001/XMLSchema#string

P2860

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.

Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole.

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients.

Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Fluconazole and Candida krusei fungemia.

Fungal diarrhoea: association of different fungi and seasonal variation in their incidence.

Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.

P304

188-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKH532

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8081403

http://www.w3.org/2001/XMLSchema#string

P698

15650001

http://www.w3.org/2001/XMLSchema#string